VIP Health Care Portfolio
Data updated: 2026-08-24
C000211329 — VIP Health Care Portfolio. United States Multi-Cap / All-Cap Blend / Core Health Care Equity. Holdings, fees, performance and SEC filings.
C000211329 Fund Overview
VIP Health Care Portfolio is a US mutual fund managed by Variable Insurance Products Fund IV, categorised as United States Multi-Cap / All-Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Variable Insurance Products Fund IV
- Category: United States Multi-Cap / All-Cap Blend / Core Health Care Equity
- Assets under management: $1.16B
- 1-year return: 29.1%
- SEC CIK: 0000720318
- SEC series ID: S000007742
- Share class ID: C000211329
C000211329 Investment Objective and Strategy
VIP Health Care Portfolio describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Variable Insurance Products Fund IV.
Investment objective
VIP Health Care Portfolio seeks capital appreciation.
Principal investment strategy
Normally investing at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. These companies may include, for example, companies engaged in the research, development, manufacturing, or marketing of products based on biotechnology research; companies engaged in research, development, or production of pharmaceuticals, including veterinary drugs; manufacturers, distributors, and wholesalers of health care equipment, devices, and supplies including drug delivery systems and eye care products; and owners and operators of health care facilities, HMOs, and other managed plans. For purposes of the fund's policy to normally invest at least 80% of its assets in securities of companies principally engaged in the business activity or activities identified for the fund, Fidelity may consider a company to be principally engaged in the designated business activity or activities based on: (i) the level of a company's assets, income, sales, or profits that are committed to, derived from, or related to the designated business activity or activities, or (ii) whether a third party has given the company an industry or sector classification consistent with the designated business activity or activities.
Whether a company is principally engaged in the designated business activity or activities can be determined under any of these factors. Derivative instruments that provide investment exposure to the investments above or exposure to one or more market risk factors associated with such investments are included in the fund's 80% policy, consistent with the fund's investment policies and limitations with respect to investments in derivatives. Normally investing primarily in common stocks. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
C000211329 Holdings
Top 10 holdings of VIP Health Care Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| ELI LILLY and CO | 7.78% |
| Danaher Corp. | 6.42% |
| Thermo Fisher Scientific, Inc. | 5.03% |
| JOHNSON and JOHNSON | 4.57% |
| Fidelity Revere Street Trust | 4.49% |
| Unitedhealth Group, Inc. | 3.88% |
| Abbvie, Inc. | 2.79% |
| Ascendis Pharma A/s | 2.31% |
| Alnylam Pharmaceuticals, Inc. | 1.96% |
| MERCK and CO INC | 1.89% |
C000211329 Portfolio Allocation
Asset-class allocation of VIP Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.6% |
| Cash & Equivalents | 5.7% |
| Fixed Income | 0.1% |
C000211329 Performance
Total returns for C000211329 (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 8.9% |
| 1 year | 29.1% |
| 3 years (annualised) | 9.5% |
| 5 years (annualised) | 4.0% |
C000211329 Risk Information
Risk metrics for C000211329, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.7%
C000211329 Costs and Fees
C000211329 costs about $84 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.84%
- Gross expense ratio: 0.84%
- Portfolio turnover: 65%
- Brokerage commissions: 3.23 bps of average net assets (SEC N-CEN)
C000211329 Cashflows
Over the 12 months to 2026-06, VIP Health Care Portfolio had net inflows of $14.32M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $1.50M |
| 2026-05 | −$3.19M |
| 2026-04 | −$7.43M |
| 2026-03 | −$7.55M |
| 2026-02 | $81.81M |
| 2026-01 | −$13.59M |
C000211329 Debt Constituents
Largest debt holdings of VIP Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Galvanize Therapeutics | 0.11% |
C000211329 Prospectus and SEC Filings
Official VIP Health Care Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-20
- Prospectus (485BPOS) — filed 2025-04-18
- Prospectus (485BPOS) — filed 2024-04-19
- Portfolio holdings (N-PORT) — filed 2026-08-24
- Portfolio holdings (N-PORT) — filed 2026-05-26
- Portfolio holdings (N-PORT) — filed 2026-02-24
- Annual census (N-CEN) — filed 2026-03-12
- Annual census (N-CEN) — filed 2025-03-14
Related Funds
Other United States Multi-Cap / All-Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.